Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple-antibiotic regimens for complicated brucellosis
IRCT2017052734154N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jun 2017
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label trial of doxycycline, rifampicin, gentamicin, ciprofloxacin and trimethoprim + sulfamethoxazole in brucellosis (3 arms), sponsored by Islamic Azad University. Started Jun 2017; status: completed.
02
Drugs
doxycyclinerifampicingentamicinciprofloxacintrimethoprim + sulfamethoxazole
03
Conditions
brucellosis
Beyond the preview
Go deeper on IRCT2017052734154N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017052734154N1.